NCT00006267 2013-07-09
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
GOG Foundation
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT00006230 2012-09-24
Nitrocamptothecin in Treating Patients With Advanced Ovarian Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00249990 2010-01-07
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
University of New Mexico
Phase 2 Completed